Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
Pharmaceutics|April 28, 2023
Pharmacokinetics and Pharmacodynamics of Antibody-Drug Conjugates Administered via Subcutaneous and Intratumoral RoutesHsuan-Ping Chang, Huyen Khanh Le, Dhaval K Shah
Journal of Pharmacokinetics and Pharmacodynamics|June 29, 2023
Clinical validation of translational antibody PBPK model using tissue distribution data generated with 89Zr-immuno-PET imagingShufang Liu, Zhe Li, Marc Huisman, et al.
British Journal of Clinical Pharmacology|May 2, 2018
Physiologically-based pharmacokinetic model of vaginally administered dapivirine ring and film formulationsKatherine Kay, Dhaval K Shah, Lisa Rohan, et al.
Journal of Pharmaceutical Sciences|June 6, 2020
Whole-Body Pharmacokinetics of Antibody in Mice Determined using Enzyme-Linked Immunosorbent Assay and Derivation of Tissue Interstitial ConcentrationsHsuan-Ping Chang, Se Jin Kim, Dhaval K Shah
The AAPS Journal|April 1, 2025
Effect of FcRn Binding on Monoclonal Antibody Disposition in the BrainHsien Wei Huang, Shengjia Wu, Shufang Liu, et al.
Advanced Drug Delivery Reviews|January 22, 2023
Nanoparticle biodistribution coefficients: A quantitative approach for understanding the tissue distribution of nanoparticlesMokshada Kumar, Priyanka Kulkarni, Shufang Liu, et al.
Cancer Chemotherapy and Pharmacology|February 10, 2011
Evaluation of combined bevacizumab and intraperitoneal carboplatin or paclitaxel therapy in a mouse model of ovarian cancerDhaval K Shah, Jean Veith, Ralph J Bernacki, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 29, 2015
HER2/ERBB2 immunoreactivity in human retinoblastomaG M Seigel, S Sharma, A S Hackam, et al.
Scientific Reports|April 14, 2022
Algorithmic multiscale analysis for the FcRn mediated regulation of antibody PK in humanDimitris G Patsatzis, Shengjia Wu, Dhaval K Shah, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 10, 2023
Expansion of platform physiologically-based pharmacokinetic model for monoclonal antibodies towards different preclinical species: cats, sheep, and dogsHsien-Wei Huang, Shengjia Wu, Ekram A Chowdhury, et al.
Pageof 11